Last reviewed · How we verify

CSL Limited Influenza Virus Vaccine

Seqirus · FDA-approved active Biologic

CSL Limited Influenza Virus Vaccine is a inactivated influenza vaccine Biologic drug developed by Seqirus. It is currently FDA-approved for Seasonal influenza prevention in adults and children.

This inactivated influenza vaccine stimulates the immune system to produce antibodies and cellular immunity against circulating influenza virus strains.

This inactivated influenza vaccine stimulates the immune system to produce antibodies and cellular immunity against circulating influenza virus strains. Used for Seasonal influenza prevention in adults and children.

At a glance

Generic nameCSL Limited Influenza Virus Vaccine
SponsorSeqirus
Drug classinactivated influenza vaccine
ModalityBiologic
Therapeutic areaImmunology / Infectious Disease
PhaseFDA-approved

Mechanism of action

The vaccine contains inactivated influenza virus particles or viral antigens that trigger both humoral (antibody) and cell-mediated immune responses. Upon vaccination, B cells produce strain-specific antibodies (primarily IgG) that neutralize circulating virus, while T cells develop memory responses for rapid recall immunity. This prevents or reduces severity of influenza infection when vaccinated individuals encounter wild-type virus.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about CSL Limited Influenza Virus Vaccine

What is CSL Limited Influenza Virus Vaccine?

CSL Limited Influenza Virus Vaccine is a inactivated influenza vaccine drug developed by Seqirus, indicated for Seasonal influenza prevention in adults and children.

How does CSL Limited Influenza Virus Vaccine work?

This inactivated influenza vaccine stimulates the immune system to produce antibodies and cellular immunity against circulating influenza virus strains.

What is CSL Limited Influenza Virus Vaccine used for?

CSL Limited Influenza Virus Vaccine is indicated for Seasonal influenza prevention in adults and children.

Who makes CSL Limited Influenza Virus Vaccine?

CSL Limited Influenza Virus Vaccine is developed and marketed by Seqirus (see full Seqirus pipeline at /company/seqirus).

What drug class is CSL Limited Influenza Virus Vaccine in?

CSL Limited Influenza Virus Vaccine belongs to the inactivated influenza vaccine class. See all inactivated influenza vaccine drugs at /class/inactivated-influenza-vaccine.

What development phase is CSL Limited Influenza Virus Vaccine in?

CSL Limited Influenza Virus Vaccine is FDA-approved (marketed).

What are the side effects of CSL Limited Influenza Virus Vaccine?

Common side effects of CSL Limited Influenza Virus Vaccine include Injection site pain, redness, or swelling, Myalgia (muscle aches), Headache, Fatigue, Low-grade fever.

Related